Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 14, 2018 07:48 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

NORTHVALE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
August 09, 2017 16:39 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2018 Ended June 30, 2017 and Provides Conference Call Information

NORTHVALE, N.J., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
February 07, 2017 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2017 Financial Results on February 13, 2017

NORTHVALE, N.J., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
January 23, 2017 08:18 ET | Source: Elite Pharmaceuticals, Inc.

Elite Reports On SequestOx™ FDA End-of-Review Meeting

NORTHVALE, N.J., Jan. 23, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported the Company received official minutes from its December 21, 2016...
December 22, 2016 12:31 ET | Source: Elite Pharmaceuticals, Inc.

Elite Provides Update on SequestOx™ New Drug Application

NORTHVALE, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today announced the Company met with the U.S. Food and Drug Administration (the...
November 05, 2015 17:12 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss 2nd Quarter 2016 Financial Results on November 10, 2015

Northvale, NJ, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of...
June 10, 2013 13:54 ET | Source: Elite Pharmaceuticals, Inc.

Elite Laboratories Files Citizen Petition With the FDA on Brompheniramine Maleate and Pseudoephedrine HCL Extended Release

NORTHVALE, N.J., June 10, 2013 (GLOBE NEWSWIRE) -- Elite Laboratories, a wholly owned subsidiary of Elite Pharmaceuticals, Inc. (collectively ""Elite" or the "Company") (OTCBB:ELTP) today announced...